Patient characteristics associated with allergen immunotherapy initiation and adherence - 10/08/11
Doi : 10.1016/j.jaci.2010.10.014
Reprint requests: Cheryl S. Hankin, PhD, BioMed Econ, LLC, PO Box 129, Moss Beach, CA 94038.Key words : Patient characteristics, allergen immunotherapy, disparities, utilization, adherence persistence
Le texte complet de cet article est disponible en PDF.
Plan
| Disclosure of potential conflict of interest: C. S. Hankin has received research support from the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma & Immunology and is president and chief scientific officer of BioMedEcon, LLC. R. F. Lockey has declared that he has no conflict of interest. |
© 2010
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 127 - N° 1
P. 46 - janvier 2011 Retour au numéro
Article précédent
- Disease-modifying effect and economic implications of sublingual immunotherapy
- Giorgio Walter Canonica, Giovanni Passalacqua
- The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article
- Philippe J. Bousquet, Moisés A. Calderón, Pascal Demoly, Désirée Larenas, Giovanni Passalacqua, Claus Bachert, Jan Brozek, G. Walter Canonica, Thomas Casale, Joao Fonseca, Ronald Dahl, Stephen R. Durham, Hans Merk, Margitta Worm, Ulrich Wahn, Torsten Zuberbier, Holger J. Schünemann, Jean Bousquet
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?